Afatinib, also known as Gilotrif, is a successful drug used to treat non-small cell lung cancer. It belongs to the non-tumor cell kinase inhibitor group of drugs. It is usually taken orally. A single pill of imatinib can effectively treat non-small cell lung cancer when it is administered with piroxicam. However, the combination of drugs does not give a complete cure.
The combination of imatinib and Afatinib is sometimes also referred as the triple therapy. A study conducted by the National Cancer Institute and the University of Illinois revealed that combining the three has improved the survival rate for ovarian cancer patients. Both gilotrif and imatinib have excellent antineoplastic properties. Both these drugs can also target brain tumors and solid tumors. When given together, gilotrif and imatinib not only target cancerous cells but also prevent the spread of cancer to other parts of the body. They also help improve the immune response and minimize the effects of chemotherapy.
The most common side effect of imatinib is elevation of serum creatinine and increased blood pressure. This is caused by the blocking of the action of the epidermal growth factor receptor on the cell membranes. This increase in blood pressure may result in heart palpitations. Patients who have suffered from this side effect of gilotrif should immediately contact their physicians and consult the Oncology department. Patients with locally advanced cancers may be prescribed additional dosages to prevent this complication.
Patients who have suffered from allergic reactions to oxygen and who use imatinib may experience breathing problems. In such cases, the patient should avoid supplemental oxygen until the problem resolves. Lung swelling, pain and fever are some of the symptoms associated with this condition. Patients should immediately notify their doctor of any respiratory symptoms.
The prolonged use of gilotrif and imatinib may cause severe liver malfunction, especially when taken with certain medications. If you take imatinib for relief from pain, the medication should be discontinued right away if you develop a serious liver disorder. People with hepatitis are warned to avoid taking this drug if they suffer from liver disease. Patients who have a history of thrombotic disorders are advised to consult their doctor before taking this medication. If you do take imatinib for relief from pain, stop taking it immediately if you develop any of the following symptoms: irregular heartbeat, vomiting, unexplained vaginal bleeding, or uncontrolled seizures.
In general, the good quality product offers no major effects. However, if you have certain conditions, such as allergies or bone disease, discuss these problems with your doctor before starting to take imatinib. Patients with renal impairment should also mention these problems to their doctor before starting to take the medicine. There are several alternative treatments available in pharmacies and online that can also help relieve the pain and symptoms of RLS. It is recommended to ask your doctor about these alternative treatment options to determine the best course of action for you.